Targeted Strategies for Today's Evolving Markets

MissionIR Blog

AcelRx Pharmaceuticals (ACRX) Presents at Rodman & Renshaw Conference

AcelRx Pharmaceuticals, Inc. (NASDAQ: ACRX) is a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of acute pain. The company’s leading product candidate, Zalviso™, is designed for the management of moderate-to-severe acute pain in adults in the hospital setting by utilizing a high therapeutic index opioid through a non-invasive delivery route via a pre-programmed, patient-controlled analgesia device. In early September, the company plans to meet with the FDA regarding the submittal of a new drug application for Zalviso. For more information, visit the company’s website at

Rodman & Renshaw is a full-service investment bank dedicated to providing corporate finance, strategic advisory, and related services to public and private companies across multiple sectors and regions. Rodman also provides research and sales and trading services to institutional investors. For more information on Rodman & Renshaw, visit
This entry was posted in Rodman and Renshaw Conference. Bookmark the permalink.

Comments are closed.